FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2117349051> ?p ?o ?g. }

• W2117349051 endingPage "2420" @default.
• W2117349051 startingPage "2415" @default.
• W2117349051 abstract "Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of endothelial nitric oxide synthase and a proposed cardiovascular risk factor, is elevated in chronic kidney disease (CKD). Pharmacological strategies that lower plasma concentration of ADMA may be expected to increase nitric oxide (NO.) bioavailability and potentially limit atherosclerosis. We hypothesized that the antioxidant alpha-tocopherol (vitamin E) reduces ADMA levels in CKD.An open-label pilot interventional study using 800 IU of vitamin E was undertaken in eight stable out-patients with non-diabetic CKD (creatinine clearance <30 ml/min/1.73 m(2)) and six healthy controls, with the objective of measuring plasma ADMA levels at baseline and after 8 weeks of treatment. Plasma ADMA, symmetric dimethylarginine (SDMA) and alpha-tocopherol concentrations were determined at study entry and exit using high-performance liquid chromatography, while plasma total F2-isoprostanes, an index of oxidative stress, were measured using a commercially available enzyme-linked immunosorbent assay kit.ADMA and SDMA concentrations were significantly higher in the plasma of patients compared with that of controls (P </= 0.001). After treatment with vitamin E, ADMA decreased by 23% in six of eight patients (P <0.001). The remaining two patients showed either an increase or no change (overall, P = 0.16). There was no significant change in plasma F2-isoprostanes with vitamin E treatment for 8 weeks.Antioxidant therapy with vitamin E has the potential to lower ADMA levels in CKD patients, implying increased NO. availability. This strategy merits further exploration in the setting of CKD prior to renal replacement." @default.
• W2117349051 created "2016-06-24" @default.
• W2117349051 creator A5021850188 @default.
• W2117349051 creator A5022334933 @default.
• W2117349051 creator A5026948617 @default.
• W2117349051 creator A5027517212 @default.
• W2117349051 creator A5030346835 @default.
• W2117349051 creator A5051094881 @default.
• W2117349051 creator A5054166936 @default.
• W2117349051 creator A5054501791 @default.
• W2117349051 creator A5066001342 @default.
• W2117349051 creator A5084515651 @default.
• W2117349051 creator A5088850153 @default.
• W2117349051 date "2003-11-01" @default.
• W2117349051 modified "2023-10-18" @default.
• W2117349051 title "Impact of vitamin E on plasma asymmetric dimethylarginine (ADMA) in chronic kidney disease (CKD): a pilot study" @default.
• W2117349051 cites W113714250 @default.
• W2117349051 cites W1962462058 @default.
• W2117349051 cites W1970798352 @default.
• W2117349051 cites W1974294958 @default.
• W2117349051 cites W1978200035 @default.
• W2117349051 cites W2004022545 @default.
• W2117349051 cites W2058774619 @default.
• W2117349051 cites W2083287299 @default.
• W2117349051 cites W2089550304 @default.
• W2117349051 cites W2114467369 @default.
• W2117349051 cites W2120785970 @default.
• W2117349051 cites W2124279221 @default.
• W2117349051 cites W2125954042 @default.
• W2117349051 cites W2132398264 @default.
• W2117349051 cites W2134924827 @default.
• W2117349051 cites W2148531805 @default.
• W2117349051 cites W2153110646 @default.
• W2117349051 cites W357660346 @default.
• W2117349051 doi "https://doi.org/10.1093/ndt/gfg406" @default.
• W2117349051 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14551376" @default.
• W2117349051 hasPublicationYear "2003" @default.
• W2117349051 type Work @default.
• W2117349051 sameAs 2117349051 @default.
• W2117349051 citedByCount "82" @default.
• W2117349051 countsByYear W21173490512012 @default.
• W2117349051 countsByYear W21173490512013 @default.
• W2117349051 countsByYear W21173490512014 @default.
• W2117349051 countsByYear W21173490512015 @default.
• W2117349051 countsByYear W21173490512016 @default.
• W2117349051 countsByYear W21173490512017 @default.
• W2117349051 countsByYear W21173490512018 @default.
• W2117349051 countsByYear W21173490512019 @default.
• W2117349051 countsByYear W21173490512020 @default.
• W2117349051 countsByYear W21173490512022 @default.
• W2117349051 crossrefType "journal-article" @default.
• W2117349051 hasAuthorship W2117349051A5021850188 @default.
• W2117349051 hasAuthorship W2117349051A5022334933 @default.
• W2117349051 hasAuthorship W2117349051A5026948617 @default.
• W2117349051 hasAuthorship W2117349051A5027517212 @default.
• W2117349051 hasAuthorship W2117349051A5030346835 @default.
• W2117349051 hasAuthorship W2117349051A5051094881 @default.
• W2117349051 hasAuthorship W2117349051A5054166936 @default.
• W2117349051 hasAuthorship W2117349051A5054501791 @default.
• W2117349051 hasAuthorship W2117349051A5066001342 @default.
• W2117349051 hasAuthorship W2117349051A5084515651 @default.
• W2117349051 hasAuthorship W2117349051A5088850153 @default.
• W2117349051 hasBestOaLocation W21173490511 @default.
• W2117349051 hasConcept C124490489 @default.
• W2117349051 hasConcept C126322002 @default.
• W2117349051 hasConcept C134018914 @default.
• W2117349051 hasConcept C159641895 @default.
• W2117349051 hasConcept C185592680 @default.
• W2117349051 hasConcept C2776151105 @default.
• W2117349051 hasConcept C2777468819 @default.
• W2117349051 hasConcept C2777551382 @default.
• W2117349051 hasConcept C2778004101 @default.
• W2117349051 hasConcept C2778653478 @default.
• W2117349051 hasConcept C2779877776 @default.
• W2117349051 hasConcept C2780306776 @default.
• W2117349051 hasConcept C2780972559 @default.
• W2117349051 hasConcept C515207424 @default.
• W2117349051 hasConcept C519581460 @default.
• W2117349051 hasConcept C55493867 @default.
• W2117349051 hasConcept C71924100 @default.
• W2117349051 hasConceptScore W2117349051C124490489 @default.
• W2117349051 hasConceptScore W2117349051C126322002 @default.
• W2117349051 hasConceptScore W2117349051C134018914 @default.
• W2117349051 hasConceptScore W2117349051C159641895 @default.
• W2117349051 hasConceptScore W2117349051C185592680 @default.
• W2117349051 hasConceptScore W2117349051C2776151105 @default.
• W2117349051 hasConceptScore W2117349051C2777468819 @default.
• W2117349051 hasConceptScore W2117349051C2777551382 @default.
• W2117349051 hasConceptScore W2117349051C2778004101 @default.
• W2117349051 hasConceptScore W2117349051C2778653478 @default.
• W2117349051 hasConceptScore W2117349051C2779877776 @default.
• W2117349051 hasConceptScore W2117349051C2780306776 @default.
• W2117349051 hasConceptScore W2117349051C2780972559 @default.
• W2117349051 hasConceptScore W2117349051C515207424 @default.
• W2117349051 hasConceptScore W2117349051C519581460 @default.
• W2117349051 hasConceptScore W2117349051C55493867 @default.
• W2117349051 hasConceptScore W2117349051C71924100 @default.
• W2117349051 hasIssue "11" @default.

• next